Arabic Arabic English English French French German German
dark

Trevena Announces Wake Forest Baptist Health Joining OLINVYK® Clinical Outcomes Study

Trevena, Inc. today announced Wake Forest Baptist Health Medical Center will join the VOLITION (“Intravenous Oliceridine and Opioid Related Complications”) study which examines the impact of OLINVYK (oliceridine) injection on respiratory, gastrointestinal (GI), and cognitive function outcomes in the postoperative setting. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Engagement, Interoperability, and the Future of the Healthcare Tech Stack

Next Post

Cardior Raises €64M Series B to Advance Clinical Pipeline of RNA Therapeutics to Treat Cardiac Disease

Related Posts
Total
0
Share